REPOCEUTICALS A/S: Financial statements 2018
CVR: 36494433
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
REPOCEUTICALS A/S (CVR 36494433) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 0 and a net result of DKK -383,311 compared with DKK -77,881 the year before. Equity in the 2018 report amounted to DKK -356,389.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK -383,311
- Equity
- DKK -356,389
- Total Assets
- DKK 5,036,211
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 0 | 0 | -383K | -356K | - |
| 2017 | - | - | -78K | 27K | - |
| 2016 | - | - | -211K | 105K | - |
| 2015 | - | - | -34K | 316K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
REPOCEUTICALS A/S has published its annual report for 2017. The net result was DKK -77,881.
About REPOCEUTICALS A/S
REPOCEUTICALS A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2015. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named REPOCEUTICALS ApS. The management consists of Torsten Bjørn. The board consists of Henrik Bulskov (chair), Charlotte Pahl and Christian Vinding Thomsen. The company's owners include NIELS ERIK JESPERSEN HOLDING ApS, Beier Holding ApS and DMZ HOLDING ApS. The company has 2 employees (2026). In 2025, the company reported revenue of DKK 88,000,000 and a net result of DKK -6,228,938,000 compared with DKK -6,274,548 the year before. Equity in the 2025 report amounted to DKK 6,245,088,000.